Actos
Brand for: Pioglitazone
My Prescription
Payment
Select pharmacy
$23.27
Print or send this coupon to your phone
AlbertsonsPowered byAbout Actos
Drug Details
Pioglitazone is an oral medication prescribed for adults managing Type 2 diabetes, used in conjunction with a suitable diet and exercise regimen. This drug belongs to the thiazolidinedione class, commonly referred to as "glitazones," and aims to enhance the body's sensitivity to insulin. By improving insulin response, pioglitazone helps lower blood sugar levels by facilitating the movement of sugar into the cells for energy and reducing sugar production in the liver. Effectively controlling blood sugar can help prevent complications such as kidney damage, blindness, nerve issues, limb loss, and sexual dysfunction. It may also decrease the risk of heart attack or stroke. Pioglitazone can be taken alone or with other diabetes medications like metformin or sulfonylureas. It is important to discuss the potential benefits and risks, including possible side effects like headaches, swelling, weight gain, and heart failure, with your healthcare provider.
Price history for Actos (brand) & Pioglitazone (generic)
90 Tablets, 15MG
Average retail price for Actos
Average retail price for Pioglitazone
Average SaveHealth price for Pioglitazone
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
Over the last 12 months, the average discount price of Actos is $26.50 using the SaveHealth savings card. That's an average savings of 96.51% on Actos with our discount card.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Actos (Pioglitazone) dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 15MG | 90 Tablets | $23.27 | $0.26 |
| 15MG | 1 Tablet | $14.09 | $14.09 |
| 15MG | 30 Tablets | $16.77 | $0.56 |
| 15MG | 60 Tablets | $19.55 | $0.33 |
| 15MG | 100 Tablets | $23.97 | $0.24 |
| 15MG | 500 Tablets | $51.50 | $0.10 |
| 30MG | 1 Tablet | $14.12 | $14.12 |
Actos FAQs
Actos and metformin are not the same. Actos (pioglitazone) and metformin are both medications used to treat type 2 diabetes, but they belong to different classes of drugs and work in different ways. Actos is a thiazolidinedione, which helps improve insulin sensitivity, while metformin is a biguanide, which decreases glucose production in the liver and improves insulin sensitivity.
The major side effect of Actos (pioglitazone) is an increased risk of heart failure. It can also cause fluid retention, which may exacerbate or lead to heart failure, especially in patients with a history of heart conditions. Other potential side effects include weight gain, liver issues, and an increased risk of fractures. It is important for patients to discuss their medical history with their healthcare provider before starting Actos.
Yes, Actos (pioglitazone) is still prescribed. It is used to help control blood sugar levels in individuals with type 2 diabetes. However, its use may be limited or monitored due to potential side effects and risks, so it is important for patients to discuss with their healthcare provider whether it is appropriate for their specific condition.
Individuals with certain medical conditions should avoid taking Actos. These include those with a history of heart failure, active bladder cancer, or severe liver disease. Additionally, people who are allergic to pioglitazone or any other ingredients in Actos should not take it. It is also important for pregnant or breastfeeding women to consult their healthcare provider before using Actos. Always consult a healthcare professional for personalized advice.
Pioglitazone carries a black box warning regarding the potential risk of causing or exacerbating congestive heart failure. Patients should be monitored for signs and symptoms of heart failure, and the medication should be discontinued if any deterioration in cardiac status occurs. It is not recommended for use in patients with symptomatic heart failure.